The largest database of trusted experimental protocols

Ag1024

Manufactured by Merck Group
Sourced in United States, Germany

AG1024 is a laboratory equipment product manufactured by Merck Group. It is designed to perform specific laboratory functions. The core function of AG1024 is to serve as a tool for researchers and scientists in their work. No further details about the intended use or interpretation of the product's capabilities are provided.

Automatically generated - may contain errors

11 protocols using ag1024

1

Genistein and AG1024 Effects on Prostate Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human PCa cell lines PC3 and DU145 were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were maintained in RPMI-1640 medium (Gibco-BRL; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Gibco-BRL; Thermo Fisher Scientific) at 37°C under 5% CO2 in a humidified incubator. For cell treatment, PC3 and DU145 cells were cultured in RPMI-1640 medium supplemented with genistein (purity >98%, Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and AG1024 (Sigma-Aldrich; Merck KGaA) at series concentrations. genistein (0, 10, 20, 30, 50 and 100 µM) and AG1024 (10 µM) (5 (link)) were dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich; Merck KGaA). X-ray irradiation was delivered using an X-6 MV photon linear accelerator (Varian Associates Inc., Palo Alto, CA, USA) at room temperature with a dose rate of 2 Gy/min (25 (link)). Cells treated with DMSO were considered as negative control for irradiation or drug treatment.
+ Open protocol
+ Expand
2

Cytotoxicity Screening of Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
U0126, AG1024, LY294002, vincristine, and daunorubicin were dissolved in dimethylsulfoxide (DMSO) and dexamethasone in 100% ethanol at stock concentrations of 10mmol/L. Cells were incubated with U0126, AG1024, vincristine, daunorubicin, or dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) at the indicated doses at 37°C for 72hours and subsequently reacted with Cell TitreGlo reagent according to the manufacturer's instructions (Promega). Luminescence was quantified using a Victor Wallac plate reader.
+ Open protocol
+ Expand
3

Purification and Characterization of HIV Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
All media, sera, and supplements were obtained from Thermo Fisher Scientific (Grand Island, NY) unless otherwise noted. All primary antibodies and LY294002 were obtained from Cell Signaling Technology ([CST], Beverly, MA). Fluconazole was obtained from Spectrum Chemicals (New Brunswick, NJ). AG1024, 3-nitroproprionic acid, pertussis toxin, and all other chemicals were obtained from Sigma (Saint Louis, MO), unless otherwise noted. Purified endotoxin-free recombinant HIV Tat (1–72) was made and characterized as previously described [9 (link), 10 (link)]. Gp120 derived from HIVIIIB and HIVSF was acquired from the NIH-AIDS repository (Bethesda, MD, USA). HIV-gp120 transgenic mice were kindly provided by Dr. Mucke at the Gladstone Institute.
+ Open protocol
+ Expand
4

Investigating IGF-I and TGF-β2 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human insulin-like growth factor I (IGF-I; 291-G1; 10 ng/ml) and transforming growth factor-β2 (TGF-β2; 302-B2-010; 10 ng/ml) were obtained from R&D Systems. A selective inhibitor of ERK1/2 (U0126; 10 μM; Cell Signaling Technology, Inc.) and allosteric inhibitor of IGF-IR (AG1024; 1 µM; Sigma-Aldrich; Merck KGaA) were used in the present study for 1 h. Primary antibodies from Santa Cruz Biotechnology, Inc. were used, and these included anti-lumican (sc166871; mouse monoclonal; 1/100 dilution for western blot analysis or 1/50 for immunofluorescence), anti-β-catenin (sc7963; mouse monoclonal; 1/300 dilution), anti-ERK1/2 (sc514302; mouse monoclonal; 1/200 dilution), anti-IGF-IR (sc81464; mouse monoclonal; 1/100 dilution), anti-pERK1/2 (sc136521; mouse monoclonal; 1/100 dilution), anti-Smad2 (sc6200; goat polyclonal; 1/200 dilution) and anti-pSmad2 (sc101801; rabbit polyclonal; 1/200 dilution). In addition, anti-actin (MAB1501; mouse monoclonal; 1/5,000 dilution; EMD Millipore), anti-p-IGF-IR (PA5-37602; polyclonal rabbit; 1/500 dilution; Thermo Fisher Scientific, Inc.), keratan sulfate (KS; 270427; mouse monoclonal; 1/1,000 dilution; Seikagaku Corporation) and keratanase II (100812; 0,005 µ/ml; Seikagaku Corporation) were utilized. Secondary-HRP antibodies anti-rabbit (AP182PR) and anti-mouse (AP192PM) were used at a 1/5,000 dilution and obtained from Millipore.
+ Open protocol
+ Expand
5

Sprague-Dawley Rat Astrocyte and Neuron Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used postnatal Sprague-Dawley rats for in vitro cultures (P3 days for astrocytes and E18 for neurons). 40 C57*B6 mice at 6–8 weeks old were used for in vivo study (10 for each group). All experiments were carried out based on medical ethics guidelines (20170223-001). KA and AG1024 (IGF-1R antagonist) were purchased from Sigma (Steinheim, Germany).
+ Open protocol
+ Expand
6

IGF-I Stimulated DNA Synthesis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA synthesis was assessed by measuring the incorporation of 5-bromo-2-deoxyuridine (BrdU) into DNA [13 (link)]. Briefly, cells were seeded in 96-well culture plates (1200 cells/well), and maintained in medium containing varying doses of IGF-I for 24h at 37° C. BrdU or phosphate buffer saline (as background control) was added to each well during the final 8h of treatment. After fixation, cells were incubated with anti-BrdU antibody for 1h at room temperature, and with substrate solution for 15 min in the dark at room temperature. The signals were quantitated using a spectrophotometric plate reader set at wavelength of 450/540 nm. To examine if high dose IGF-I also activated the other signaling pathways to stimulate DNA synthesis, cells were treated with IGF-I and AG1024 (Sigma Aldrich, MO, USA) concomitantly.
+ Open protocol
+ Expand
7

Biglycan and IGF-I Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human biglycan (2667-CM) and IGF-I (insulin-like growth factor I; 291-G1) were obtained from R&D Diagnostics. Selective inhibitor of ERK1/2 (Cell Signaling Technology; U016) and allosteric inhibitor of IGF-IR (Sigma-Aldrich; AG1024) were used in this study. Primary antibodies from Santa Cruz Biotechnology used, anti-biglycan (sc100857; mouse monoclonal; 1/100 dilution), anti-β catenin (sc7963; mouse monoclonal; 1/300 dilution and 1/50 for immunofluorescence experiments), anti-IGF-IR total (sc81464; mouse monoclonal; 1/100 dilution), anti-pERK1/2 (sc136521; mouse monoclonal; 1/100 dilution) and anti-fibrillarin (sc374022; 1/100 dilution). In addition, anti-actin (Millipore MAB1501; mouse monoclonal; 12 ,500 dilution), anti-ERK total (Thermo scientific MA5-15343; mouse monoclonal; 1/500 dilution), anti-pIGF-IR (Thermo scientific PA5-37602; polyclonal rabbit; 1/500 dilution for western blot and 1/50 for immunofluorescence experiments), anti-tubulin (Sigma-Aldrich T4026; monoclonal mouse; 1/1,000 dilution) and anti-LRP6 (Elabscience E-AB17347; rabbit polyclonal; 1/50 dilution) were utilized. Secondary-HRP antibodies anti-rabbit (AP182PR); and anti-mouse (AP192PM) were used in a 1/3,000 dilution and obtained from Millipore.
+ Open protocol
+ Expand
8

Humanized Monoclonal Antibodies and IGF1R Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
MK-0646 (Dalotuzumab; Merck, Sharp and Dohme Ltd., Whitehouse Station, NJ, USA) and A12 (Cixutumumab; ImClone Systems, New York, NY, USA) are humanized IgG1 monoclonal antibodies antagonist to the human IGF1R [60 (link), 61 (link)]. The antibodies were diluted in 20 mM histidine and 150 μM NaCl and used at a concentration of 10 mg/ml. AEW541 (Novartis Pharma, Basel, Switzerland) and AG1024 (Sigma-Aldrich Ltd, St. Louis, MO, USA) are selective IGF1R tyrosine kinase inhibitors. AEW541 and AG1024 were kept as a stock solution (10 mM) in DMSO and stored at –20° C. AEW541 is a reversible, ATP-competitive phosphorylation inhibitor that exhibits high selectivity towards IGF1R over insulin receptor [62 (link)]. AG1024 belongs to the tyrphostin family of tyrosine kinase inhibitors [63 (link)].
+ Open protocol
+ Expand
9

Recombinant IGF-I and IGF-IR Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human, recombinant IGF-I was purchased from Gropep (Adelaide, Australia) and an IGF-IR inhibitor, AG1024, was obtained from Sigma-Aldrich, Dorset, UK.
+ Open protocol
+ Expand
10

Reagents for Cell Culture Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture media (DMEM/F12, RPMI-1640, phenol red-free RPMI-1640), FBS, and charcoal-stripped FBS were purchased from Thermo Fisher Scientific. The IGF-1 receptor antagonist AG 1024 was purchased from EMD Millipore. The SCD-1 inhibitor A939572 was purchased from Biovision. 17β-estradiol (17β-ED), IGF-1, 4-OH tamoxifen, and DMSO were purchased from Sigma-Aldrich. 17β-ED and 4-OH tamoxifen were dissolved in ethanol, IGF-1 was prepared in sterile water and both A939572 and AG 1024 were prepared in DMSO.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!